Data from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Authors:
  • XMXueying Mao
    Xueying Mao
  • YYYongwei Yu
    Yongwei Yu
  • LBLara K. Boyd
    Lara K. Boyd
  • GRGuoping Ren
    Guoping Ren
  • DLDongmei Lin
    Dongmei Lin
  • TCTracy Chaplin
    Tracy Chaplin
  • SKSakunthala C. Kudahetti
    Sakunthala C. Kudahetti
  • ESElzbieta Stankiewicz
    Elzbieta Stankiewicz
  • LXLiyan Xue
    Liyan Xue
  • LBLuis Beltran
    Luis Beltran
  • MGManu Gupta
    Manu Gupta
  • ROR. Tim D. Oliver
    R. Tim D. Oliver

Abstract
Prostate cancer is significantly more common in Western men than in Asian men, but the basis for this difference remains unknown. Because genomic studies of Asian prostate cancer are very limited, we used a genome-wide approach to reveal the genomic alterations in Chinese prostate cancers. We found a significant reduction in the frequency of certain somatic genomic changes that are commonly found in Western prostate cancers, including the 21q22.2-22.3 deletion, which involves the TMPRSS2:ERG fusion gene, and 10q deletion, which causes PTEN inactivation. Array results were confirmed by PCR-based molecular copy-number counting in selected samples. The different frequencies of these genomic changes were further evaluated by fluorescent in situ hybridization and immunohistochemistry analyses of tissue microarray samples. These alterations might be key genetic changes underlying the regional/ethnic difference in clinical incidence and might be induced by specific environmental and/or genetic risk factors that Western men are exposed to. Our findings suggest that tumors arise in Western and Chinese populations by alternative pathogenetic mechanisms. Cancer Res; 70(13); 5207–12. ©2010 AACR.